Women's Health Initiative Updated Analysis Shows No Increased Risk of Breast Cancer with Estrogen-Alone

Office of the Director - April 11, 2006

"Longer follow-up is needed to fully explain the reduced number of breast cancers in women taking estrogen. However, this new analysis does not alter the overall conclusion from the WHI that hormones, including estrogen-alone and estrogen plus progestin, should not be used for the prevention of chronic disease," said NHLBI Director and WHI Director Elizabeth G. Nabel, M.D. "The findings still support current recommendations that hormone therapy should only be used to treat menopausal symptoms and should be used at the smallest effective dose for the shortest possible time."

For more information, please read the NIH/NHLBI News Release "WHI Updated Analysis: No Increased Risk of Breast Cancer with Estrogen-Alone."

Twitter

Facebook

YouTube